March 27, 2009 - The Philips HeartStart MRx monitor/defibrillator now includes new clinical decision support tools, updated data management solutions and next-generation Q-CPR technology to help reduce critical time to lifesaving treatment.

March 27, 2009 - Siemens Healthcare demonstrates fast speed and low dose for cardiac applications with the SOMATOM Definition Flash dual source computed tomography (CT) scanner at the 58th Annual Scientific Session of the American College of Cardiology (ACC) from March 29-31 in Orlando, FL, at booth #1842.

March 27, 2009 - Physio-Control Inc. has received FDA clearance to market its LIFEPAK 15 monitor/defibrillator in the U.S.

Siemens Healthcare’s syngo Dynamics (cardio PACS) is designed to help improve efficiency of clinical procedures in cardiovascular imaging. The upcoming version 8.01 will include features that extend throughout the entire cardiology workflow.

March 26, 2009 – Abiomed Inc. will exhibit its portfolio of heart recovery products spanning the continuum of cardiovascular patient care from the cath lab to the surgery suite at ACC 2009 in Orlando, FL, next week.

March 26, 2009 - Digirad Corp. has received 510(k) clearance from the FDA to market and manufacture its Cardius X-ACT imaging system.

March 26, 2009 - The American College of Cardiology (ACC) and the American Heart Association (AHA), in collaboration with the International Society for Heart and Lung Transplantation, have joined efforts to produce updated heart failure guidelines that focus on key research findings and clinical advances.

March 25, 2009 – GE Healthcare launched Alcyone Technology, a nuclear cardiology SPECT platform combining cadmium zinc telluride (CZT) detectors, focused pin-hole collimation, 3D reconstruction and stationary data acquisition, designed to improve workflow, dose management and overall image quality.

GE Healthcare's 1.5T magnetic resonance (MR) scanner, Discovery MR450, offers some of the most advanced capabilities available on any 1.5T system, including real-time cardiac imaging, single-acquisition, multi-contrast abdominal images with outstanding fat/water separation and ultra high-resolution musculoskeletal exams with high patient throughput.

March 25, 2009 - Siemens Healthcare Diagnostics’ C-reactive protein (hsCRP) test is cleared by the FDA for use as a predictor of risk for cardiovascular disease, and educational materials about the cardiac utility of the hsCRP test will be available in the company's booth (#1842) at the American College of Cardiology’s (ACC) Annual Scientific Session, March 29-31 in Orlando, FL.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now